Document Detail


Internal tandem duplications of the FLT3 and MLL genes are mainly observed in atypical cases of therapy-related acute myeloid leukemia with a normal karyotype and are unrelated to type of previous therapy.
MedLine Citation:
PMID:  11753604     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Eighty-two unselected cases of therapy-related myelodysplasia (t-MDS) or acute myeloid leukemia (t-AML) were investigated for internal tandem duplications of the FLT3 gene (FLT3/ITD), for internal tandem duplications of the MLL gene (MLL/ITD) and for mutations of the WT1 gene. FLT3/ITD were observed in three patients, another two patients presented MLL/ITD whereas mutations of the WT1 gene were not observed. All FLT3/ITD included the tyrosine-rich stretch between codons 589 and 599, and both MLL/ITD presented break points within Alu-repeats, as previously observed in de novo AML. The ITD were not related to any specific type of previous therapy, but three out of the five cases were observed among only six patients with overt t-AML and a normal karyotype (P = 0.0043). Interestingly, one of the patients with FLT3/ITD presented overt t-AML of subtype M1 with a normal karyotype after treatment with an alkylating agent. Complete remission was observed following treatment with daunorubicin and cytosine arabinoside, but after 37 months the patient relapsed with t-AML of subtype M3 with a t(15;17) and the same FLT3/ITD was still present. Thus FLT3/ITD may in this case represent a primary event in leukemogenesis, whereas the t(15;17) may represent a secondary event most likely induced by subsequent therapy. In conclusion, FLT3/ITD and MLL/ITD are mainly observed in uncharacteristic cases of t-AML with a normal karyotype and unrelated to previous therapy for which reason they could represent sporadic cases of de novoAML.
Authors:
D H Christiansen; J Pedersen-Bjergaard
Related Documents :
7615044 - Assessment of minimal residual disease in acute promyelocytic leukaemia with t(15;17) b...
19963144 - Acute myeloid leukemia with t(16;21)(q24;q22) and eosinophilia: case report and review ...
17928884 - Hyperdiploid karyotypes in acute myeloid leukemia define a novel entity: a study of 38 ...
7889504 - Translocation (2;3)(p22;q28) is associated with myeloid disorders.
6862444 - Human chromosomal polymorphism. vii. the distribution of chromosomal q-polymorphic band...
8108424 - Disomic locus content mapping.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Leukemia     Volume:  15     ISSN:  0887-6924     ISO Abbreviation:  Leukemia     Publication Date:  2001 Dec 
Date Detail:
Created Date:  2001-12-25     Completed Date:  2002-01-22     Revised Date:  2013-03-04    
Medline Journal Info:
Nlm Unique ID:  8704895     Medline TA:  Leukemia     Country:  England    
Other Details:
Languages:  eng     Pagination:  1848-51     Citation Subset:  IM    
Affiliation:
Section of Hematology and Oncology, Cytogenetic Laboratory, Department of Clinical Genetics, Juliane Marie Centre, Section 4052, Rigshospitalet, Blegdamsvej 9, 2100 Copenhagen Ø, Denmark.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acute Disease
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols / adverse effects
Base Sequence
Combined Modality Therapy / adverse effects
DNA, Neoplasm / analysis,  genetics
DNA-Binding Proteins / genetics*
Female
Gene Duplication / drug effects*
Humans
Karyotyping
Leukemia, Myeloid / etiology,  genetics*
Male
Middle Aged
Mutation
Myeloid-Lymphoid Leukemia Protein
Neoplasms, Second Primary / etiology,  genetics*
Proto-Oncogene Proteins / genetics*
Proto-Oncogenes*
Receptor Protein-Tyrosine Kinases / genetics*
Tandem Repeat Sequences / genetics
Transcription Factors*
Translocation, Genetic
WT1 Proteins / genetics
fms-Like Tyrosine Kinase 3
Chemical
Reg. No./Substance:
0/DNA, Neoplasm; 0/DNA-Binding Proteins; 0/MLL protein, human; 0/Proto-Oncogene Proteins; 0/Transcription Factors; 0/WT1 Proteins; 149025-06-9/Myeloid-Lymphoid Leukemia Protein; EC 2.7.10.1/FLT3 protein, human; EC 2.7.10.1/Receptor Protein-Tyrosine Kinases; EC 2.7.10.1/fms-Like Tyrosine Kinase 3

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Clinical importance of interphase cytogenetics detecting occult chromosome lesions in myelodysplasti...
Next Document:  Nitric oxide enhancement of fludarabine cytotoxicity for B-CLL lymphocytes.